Prevalences of diabetes 2010

Size: px
Start display at page:

Download "Prevalences of diabetes 2010"

Transcription

1 TESTING WITH A PURPOSE: MAKING SMBG WORTHWILE Prof. Dr. Oliver Schnell Executive Member of the Managing Board Diabetes Research Institute, Diabetes Research Group at the Helmholtz Center Munich / Neuherberg, Germany Prevalences of diabetes Prevalences of diabetes

2 SMBG in diabetes: focus on the individual An Example of Low-intensity SMBG Provided in the IDF Guidelines International Diabetes Federation Guidelines 2009, page 31 An Example of Focused SMBG Provided in the IDF Guidelines International Diabetes Federation Guidelines 2009, page 29

3 Summary of IDF Guidelines Purposes of SMBG: - Enhance the understanding of diabetes as part of patient education - Facilitate/enhance healthy behaviors - Facilitate timely treatment initiation and titration optimization SMBG should be used only when patients and clinicians have the knowledge, skills and willingness to incorporate SMBG monitoring and therapy adjustment into their diabetes care plan SMBG protocols (intensity and frequency) should be individualized to address each individual s specific educational, behavioral and clinical requirements International Diabetes Federation Guidelines 2009 Consensus Statement of Self-Monitoring of Blood Glucose in Diabetes A European Perspective Intensified insulin treatment 4-8 tests every day SMBG should be performed primarily preprandially and at bedtime Postprandial testing 7-10 times per week Nocturnal testing once a week Schnell O, Alawi A, Battelino T, Ceriello A, Diem P, Felton A, Grzeszczak W, Harno K, Kempler P, Satman I, Verges B. European Consensus Statement on Self-Monitoring of Blood Glucose in Diabetes. Diabetes, Stoffw Herz 2009; 18:

4 Consensus Statement of Self-Monitoring of Blood Glucose in Diabetes A European Perspective Individual situations Diabetic patients on oral glucose lowering agents: - To provide information on hypoglycemia - To assess glucose excursions - To assess medication and live style changes - To monitor during intercurrent illness Schnell O, Alawi A, Battelino T, Ceriello A, Diem P, Felton A, Grzeszczak W, Harno K, Kempler P, Satman I, Verges B. European Consensus Statement on Self-Monitoring of Blood Glucose in Diabetes. Diabetes, Stoffw Herz 2009; 18: Consensus Statement on SMBG A European Perspective Diabetes and Coronary Artery Disease, Neuropathy and Hypoglycemia Unawareness - Frequent testings are recommended to help recognize episodes of hypoglycaemia - More frequent nocturnal testings in patients experiencing severe hypoglycemia Schnell O, Alawi A, Battelino T, Ceriello A, Diem P, Felton A, Grzeszczak W, Harno K, Kempler P, Satman I, Verges B. European Consensus Statement on Self-Monitoring of Blood Glucose in Diabetes. Diabetes, Stoffw Herz 2009; 18: Paediatric patient with type 1 diabetes 2. Patient with gestational diabetes 3. Type 2 diabetic patient with elevated postprandial blood glucose 4. Type 2 diabetic patient with lack of motivation and adherence 5. Type 2 diabetic patient at risk of hypoglycemia or with hypoglycemia 6. Obese Type 2 diabetic patient with OAD and initiation of insulin therapy 7. Type 2 diabetic patient with coronary artery disease 8. Type 2 diabetic patient with nephropathy 9. Elderly type 2 diabetic patient Diabetes, Stoffwechsel und Herz 2010; 19:

5

6 Diabetes, Stoffwechsel und Herz 2010; 19: Diabetes, Stoffwechsel und Herz 2010; 19: Diabetes, Stoffwechsel und Herz 2010; 19:

7 Making SMBG worthwhile: the flow of implementation Clinical studies, meta-analyses, clinical experience Global and international guidelines Regional guidelines, localization Individual cases and individual strategies SMBG recommendations Guidelines and standardized recommendations are helpful for further implementing SMBG as an efficacious strategy International guidelines need to be broken down to national and regional levels (localization) Individual clinical SMBG strategies are needed Consensus strategies on clinical cases of SMBG support the aim of tailored and patient-focused approaches of SMBG International Diabetes Federation Guidelines 2009

Personalized Therapy Algorithms for Type 2 Diabetes: A Phenotypization-based Approach

Personalized Therapy Algorithms for Type 2 Diabetes: A Phenotypization-based Approach Personalized Therapy Algorithms for Type 2 Diabetes: A Phenotypization-based Approach Riccardo Candido on behalf of the Personalized Therapy AMD Study Group Diabetes Canter A.S.S. 1 Triestina, Italy BACKGROUND

More information

British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes

British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes Introduction Self-monitoring of blood glucose (SMBG) is in widespread use among

More information

Self-Monitoring Of Blood Glucose (SMBG)

Self-Monitoring Of Blood Glucose (SMBG) Self-Monitoring Of Blood Glucose (SMBG) Aim(s) and objective(s) It is important is to ensure that people with Diabetes are given the opportunity to self monitor their blood glucose appropriately as an

More information

Algorithms for Glycemic Management of Type 2 Diabetes

Algorithms for Glycemic Management of Type 2 Diabetes KENTUCKY DIABETES NETWORK, INC. Algorithms for Glycemic Management of Type 2 Diabetes The Diabetes Care Algorithms for Type 2 Diabetes included within this document are taken from the American Association

More information

The Economic Impact and Cost-Effectiveness of Glucose Monitoring

The Economic Impact and Cost-Effectiveness of Glucose Monitoring The Economic Impact and Cost-Effectiveness of Glucose Monitoring William H. Herman, MD, MPH Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes Professor of Internal Medicine and Epidemiology University

More information

Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner

Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner Challenges in Glycemic Control in Adult and Geriatric Patients Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner Provide an overview of diabetes prevalence; discuss challenges and barriers

More information

Therapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2

Therapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2 Ministry of Health, Malaysia 2010 First published March 2011 Perkhidmatan Diabetes dan Endokrinologi Kementerian Kesihatan Malaysia Practical guide to Insulin Therapy in Type 2 Diabetes Mellitus Quick

More information

Module I October 18-22, 2015 JW Marriott Marquis Hotel, Dubai, UAE

Module I October 18-22, 2015 JW Marriott Marquis Hotel, Dubai, UAE CME Accreditation is under process Module 1: Diabetes Facts and Diabetes in the Clinic Module 2: Nursing theory and educational (pedagogical) tools to advise and educate people with diabetes and their

More information

The basal plus strategy. Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE

The basal plus strategy. Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE The basal plus strategy Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE ADA/EASD guidelines recommend use of basal insulin as early as the second step

More information

WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES?

WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES? Christian In better control with his pump since 2012 WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES? Many people with Type 1 diabetes worry about potential long-term

More information

Insulin Therapy In Type 2 DM. Sources of support. Agenda. Michael Fischer, M.D., M.S. The underuse of insulin Insulin definition and types

Insulin Therapy In Type 2 DM. Sources of support. Agenda. Michael Fischer, M.D., M.S. The underuse of insulin Insulin definition and types Insulin Therapy In Type 2 DM Michael Fischer, M.D., M.S. Sources of support NaRCAD is supported by a grant from the Agency for Healthcare Research and Quality My current research projects are funded by

More information

Insulin Initiation and Intensification

Insulin Initiation and Intensification Insulin Initiation and Intensification ANDREW S. RHINEHART, MD, FACP, CDE MEDICAL DIRECTOR AND DIABETOLOGIST JOHNSTON MEMORIAL DIABETES CARE CENTER Objectives Understand the pharmacodynamics and pharmacokinetics

More information

Diabetes and Heart Disease

Diabetes and Heart Disease Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the

More information

Insulin-Treated Diabetes. Guidelines for assessment of fitness to work as Cabin Crew

Insulin-Treated Diabetes. Guidelines for assessment of fitness to work as Cabin Crew Insulin-Treated Diabetes Guidelines for assessment of fitness to work as Cabin Crew General Considerations As with all medical guidelines it is important that each individual case is assessed on its own

More information

Diabetes Fundamentals

Diabetes Fundamentals Diabetes Fundamentals Prevalence of Diabetes in the U.S. Undiagnosed 10.7% of all people 20+ 23.1% of all people 60+ (12.2 million) Slide provided by Roche Diagnostics Sources: ADA, WHO statistics Prevalence

More information

Mafauzy Mohamad Health Campus University Sains Malaysia. Declared no potential conflict of interest

Mafauzy Mohamad Health Campus University Sains Malaysia. Declared no potential conflict of interest International guidelines for the management of diabetes: evidence based medicine vs personalized medicine Mafauzy Mohamad Health Campus University Sains Malaysia Declared no potential conflict of interest

More information

DIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa

DIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa DIABETES A chronic, debilitating and often deadly disease Diabetes is a chronic condition that arises when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin

More information

When and how to start insulin: strategies for success in type 2 diabetes

When and how to start insulin: strategies for success in type 2 diabetes 1 When and how to start insulin: strategies for success in type diabetes Treatment of type diabetes in 199: with each step treatment gets more complex Bruce H.R. Wolffenbuttel, MD PhD Professor of Endocrinology

More information

NCT00272090. sanofi-aventis HOE901_3507. insulin glargine

NCT00272090. sanofi-aventis HOE901_3507. insulin glargine These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: Generic drug name:

More information

Glycaemic Control in Adults with Type 1 Diabetes

Glycaemic Control in Adults with Type 1 Diabetes Glycaemic Control in Adults with Type 1 Diabetes Aim(s) and objective(s) This document aims to provide guidance on good clinical practice in managing glycaemic control in adult patients with Type 1 Diabetes

More information

INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT

INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT APIRADEE SRIWIJITKAMOL DIVISION OF ENDOCRINOLOGY AND METABOLISM DEPARTMENT OF MEDICINE FACULTY OF MEDICINE SIRIRAJ HOSPITOL QUESTION 1 1. ท านเคยเป นแพทย

More information

DIABETES MELLITUS GUIDELINES

DIABETES MELLITUS GUIDELINES DIABETES MELLITUS GUIDELINES Virginia Premier Health Plan Virginia Premier Health Plan, Clinical Practice Guideline-Diabetes 1. Population screening a. Indications i. Adults of any age with body mass index

More information

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,

More information

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease Diabetes, prediabetes and cardiovascular disease Classes of recommendations Levels of evidence Recommended treatment targets for patients with diabetes and CAD Definition, classification and screening

More information

Insulin Pump and Supplies Policy and Administration Manual. September 2012. Assistive Devices Program Ministry of Health and Long-Term Care

Insulin Pump and Supplies Policy and Administration Manual. September 2012. Assistive Devices Program Ministry of Health and Long-Term Care Insulin Pump and Supplies Policy and Administration Manual Assistive Devices Program Ministry of Health and Long-Term Care Table of Amendments This page will list all substantive changes to policies and

More information

Insulin: Breaking Barriers Enhancing Therapies. Jerry Meece, RPh, FACA, CDE [email protected]

Insulin: Breaking Barriers Enhancing Therapies. Jerry Meece, RPh, FACA, CDE jmeece12@cooke.net Insulin: Breaking Barriers Enhancing Therapies Jerry Meece, RPh, FACA, CDE [email protected] Questions To Address Who are candidates for insulin? When do we start insulin? How do the different types of

More information

Self-Monitoring of Blood Glucose (SMBG)

Self-Monitoring of Blood Glucose (SMBG) Self-Monitoring of Blood Glucose (SMBG) Marie Russell, MD, MPH Deputy Chief Medical Officer Phoenix Area Indian Health Service IHS Division of Diabetes September 2013 Objectives History of SMBG Use and

More information

Insulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults

Insulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults Insulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults Stock # 45-11647 Revised 10/28/10 Glycemic Goals 1,2 Individualize goal based on patient risk factors A1c 6%

More information

Part B: 3 3. DIABETES MELLITUS. 3.1.1 Effects of diabetes on driving. 3.1.2 Evidence of crash risk. 3.2.1 Hypoglycaemia

Part B: 3 3. DIABETES MELLITUS. 3.1.1 Effects of diabetes on driving. 3.1.2 Evidence of crash risk. 3.2.1 Hypoglycaemia 3. DIABETES MELLITUS Refer also to section 6 Neurological conditions, section 2 Cardiovascular conditions, section 8 Sleep disorders section 10 Vision eye disorders. 3.1 Relevance to the driving task 3.1.1

More information

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused

More information

Diabetes in Pregnancy: Management in Labour

Diabetes in Pregnancy: Management in Labour 1. Purpose The standard management of labour applies to women with diabetes, and includes the following special considerations: Timing of birth. Refer to guideline: Diabetes Mellitus - Management of Pre-existing

More information

Disability Evaluation Under Social Security

Disability Evaluation Under Social Security Disability Evaluation Under Social Security Revised Medical Criteria for Evaluating Endocrine Disorders Effective June 7, 2011 Why a Revision? Social Security revisions reflect: SSA s adjudicative experience.

More information

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University Tuberculosis And Diabetes Dr. hanan abuelrus Prof.of internal medicine Assiut University TUBERCULOSIS FACTS More than 9 million people fall sick with tuberculosis (TB) every year. Over 1.5 million die

More information

ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes

ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes DIABETES MELLITUS DEFINITION It is a common, chronic, metabolic syndrome characterized by hyperglycemia as a cardinal biochemical feature. Resulting from absolute lack of insulin. Abnormal metabolism of

More information

Diabetes: When To Treat With Insulin and Treatment Goals

Diabetes: When To Treat With Insulin and Treatment Goals Diabetes: When To Treat With Insulin and Treatment Goals Lanita. S. White, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor of Pharmacy Practice, UAMS College of Pharmacy

More information

Diabetes mellitus. Lecture Outline

Diabetes mellitus. Lecture Outline Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Haidar A, Legault L, Matteau-Pelletier L, et

More information

Diabetes Dispatch. Children with Type 2 Diabetes: How do we treat them? A L A S K A N A T I V E D I A B E T E S T E A M. Inside this issue:

Diabetes Dispatch. Children with Type 2 Diabetes: How do we treat them? A L A S K A N A T I V E D I A B E T E S T E A M. Inside this issue: A L A S K A N A T I V E D I A B E T E S T E A M Diabetes Dispatch Volume 8, Issue 1 Spring 2013 Compiled by Justin Park, Pharm.D. Candidate Type 2 diabetes is a relatively new disease in children and adolescents.

More information

DM Management in Elderly- What are the glucose targets?

DM Management in Elderly- What are the glucose targets? DM Management in Elderly- What are the glucose targets? AFSHAN ZAHEDI, BASC, MD, FRCP(C) ENDOCRINOLOGY WOMEN S COLLEGE HOSPITAL ASSISTANT PROFESSOR OF MEDICINE UNIVERSITY OF TORONTO NOVEMBER 2, 2011 Disclosures

More information

Section 5: Type 2 Diabetes

Section 5: Type 2 Diabetes SECTION OVERVIEW Definition and Symptoms Blood Glucose Monitoring Healthy Eating Physical Activity Oral Medication Insulin Sharps Disposal Definition and Symptoms Type 2 diabetes is occurring more frequently

More information

BACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes

BACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes BACKGROUND More than 25% of people with diabetes take insulin ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes Insulin identified as the most effective

More information

(30251) Insulin SQ Prandial Carbohydrate

(30251) Insulin SQ Prandial Carbohydrate Diagnosis Patient MUST BE educated using carbohydrate counting for prial insulin coverage before hospitalization to be eligible for this order set Nursing Metered Glucose (Single Select Section) Metered

More information

LESSON TWO: COMPARE AND CONTRAST TYPE 1 AND TYPE 2 DIABETES

LESSON TWO: COMPARE AND CONTRAST TYPE 1 AND TYPE 2 DIABETES LESSON TWO: COMPARE AND CONTRAST TYPE 1 AND TYPE 2 DIABETES FOCUS: Students will be given information on the two major types of diabetes, and they will analyze how the two types compare and contrast. OBJECTIVES:

More information

SCHOOL DISTRICT #22 VERNON DIABETES POLICY

SCHOOL DISTRICT #22 VERNON DIABETES POLICY SCHOOL DISTRICT #22 VERNON DIABETES POLICY A student with diabetes does not automatically qualify for additional support. The student may qualify as a temporary D category (chronic health) after diagnosis

More information

IMPROVED METABOLIC CONTROL WITH A FAVORABLE WEIGHT PROFILE IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH INSULIN GLARGINE (LANTUS ) IN CLINICAL

IMPROVED METABOLIC CONTROL WITH A FAVORABLE WEIGHT PROFILE IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH INSULIN GLARGINE (LANTUS ) IN CLINICAL 464 IMPROVED METABOLIC CONTROL WITH A FAVORABLE WEIGHT PROFILE IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH INSULIN GLARGINE (LANTUS ) IN CLINICAL PRACTICE STEPHAN A SCHREIBER AND ANIKA RUßMAN ABSTRACT

More information

Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.

Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body. International Diabetes Federation Diabetes Background Information Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.

More information

TYPE 2 DIABETES SEQUENTIAL INSULIN STRATEGIES

TYPE 2 DIABETES SEQUENTIAL INSULIN STRATEGIES TYPE 2 DIABETES SEQUENTIAL INSULIN STRATEGIES Non-insulin regimes Basal insulin only (usually with oral agents) Number of injections 1 Regimen complexity Low Basal insulin +1 meal-time rapidacting insulin

More information

ADJUSTING INSULIN DOSES CONFLICTS OF INTEREST

ADJUSTING INSULIN DOSES CONFLICTS OF INTEREST ADJUSTING INSULIN DOSES CONFLICTS OF INTEREST Vahid Mahabadi, MD Research grants from Sanofi and Amylin Pharmaceutical Companies Mayer B. Davidson, MD Advisory Board Sanofi Pharmaceutical Company Chief

More information

Type 1 Diabetes ( Juvenile Diabetes)

Type 1 Diabetes ( Juvenile Diabetes) Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.

More information

DISCOVERY HEALTH MATTERS. Diabetes - a growing problem

DISCOVERY HEALTH MATTERS. Diabetes - a growing problem DISCOVERY HEALTH MATTERS Diabetes - a growing problem Vol 13 2013 Discovery Health Matters Discovery Health Matters is a layman s guide to important, but often misunderstood topics in healthcare. The information

More information

DR. Trinh Thi Kim Hue

DR. Trinh Thi Kim Hue TYPE 2 DIABETES IN THE CHILD AND ADOLESCENT DR. Trinh Thi Kim Hue CONTENTS Definition Diagnosis Treatment Comorbidities and Complications Comorbidities and Complications Screening for T2D References DEFINITION

More information

Baskets of Care Diabetes Subcommittee

Baskets of Care Diabetes Subcommittee Baskets of Care Diabetes Subcommittee Disclaimer: This background information is not intended to be a comprehensive scientific discussion of the topic, but rather an attempt to provide a baseline level

More information

A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or

A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or A Simplified Approach to Initiating Insulin When to Start Insulin: 1. Fasting plasma glucose (FPG) levels >250 mg/dl or 2. Glycated hemoglobin (A1C) >10% or 3. Random plasma glucose consistently >300 mg/dl

More information

Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks

Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks Background: Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks Final Background and Scope November 19, 2015 The Centers for Disease Control

More information

Are insulin analogs worth their cost in type 2 diabetes?

Are insulin analogs worth their cost in type 2 diabetes? Keystone, Colorado 2012 Are insulin analogs worth their cost in type 2 diabetes? Dr. Amanda Adler Consultant Physician, Institute of Metabolic Sciences Addenbrooke s Hospital, Cambridge Chair, Technology

More information

Diabetes Monitoring Diary

Diabetes Monitoring Diary Diabetes Monitoring Diary For those Counting Diabetes Service My targets: Before breakfast Before other meals Before bed... mmol/l... mmol/l... mmol/l Correcting high blood glucose levels: Information

More information

TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care

TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY Understanding the Complications That May Happen Without Proper Care STAYING HEALTHY THE IMPORTANCE OF PROPER MANAGEMENT OF TYPE 2 DIABETES Diabetes is

More information

Steroid Therapy and Management of Hyperglycaemia

Steroid Therapy and Management of Hyperglycaemia Steroid Therapy and Management of Hyperglycaemia Table of Contents Rationale...1 Scope of guidelines...2 Outcome statement...2 Aims of management...2 Effects of glucocorticoids...2 Types of steroids commonly

More information

Insulin Pump Therapy for Type 1 Diabetes

Insulin Pump Therapy for Type 1 Diabetes Insulin Pump Therapy for Type 1 Diabetes Aim(s) and objective(s) This guideline has been developed to describe which patients with Type 1 Diabetes should be referred for assessment for insulin pump therapy

More information

An Interprofessional Approach to Diabetes Management

An Interprofessional Approach to Diabetes Management Disclosures An Interprofessional Approach to Diabetes Management Principal in DiabetesReframed, LLC. Inventor of U.S. Provisional Patent Application No. 61/585,483 METHODS OF USING A DIABETES CROSS- DISCIPLINARY

More information

Type 2 Diabetes: When to Initiate And Intensify Insulin Therapy. Julie Bate on behalf of: Dr John Wilson Endocrinologist Capital and Coast DHB

Type 2 Diabetes: When to Initiate And Intensify Insulin Therapy. Julie Bate on behalf of: Dr John Wilson Endocrinologist Capital and Coast DHB Type 2 Diabetes: When to Initiate And Intensify Insulin Therapy Julie Bate on behalf of: Dr John Wilson Endocrinologist Capital and Coast DHB Declarations I have received travel funding and speaker fees

More information

Lipodystrophy: Metabolic and Clinical Aspects. Resource Room Slide Series

Lipodystrophy: Metabolic and Clinical Aspects. Resource Room Slide Series Lipodystrophy: Metabolic and Clinical Aspects Resource Room Slide Series Current Thinking About the Diagnosis and Treatment of the Insulin-Resistant State: How to Use Insulin Therapy Irl B. Hirsch, MD

More information

Starting patients on the V-Go Disposable Insulin Delivery Device

Starting patients on the V-Go Disposable Insulin Delivery Device Starting patients on the V-Go Disposable Insulin Delivery Device A simple guide for your practice For adult patients with Type 2 diabetes on basal insulin who need to take the next step Identify appropriate

More information

Lead Clinician(S) (DATE) Approved by Diabetes Directorate on: Approved by Medicines Safety Group on: This guideline should not be used after end of:

Lead Clinician(S) (DATE) Approved by Diabetes Directorate on: Approved by Medicines Safety Group on: This guideline should not be used after end of: Guideline for members of the diabetes team and dietetic department for advising on insulin dose adjustment and teaching the skills of insulin dose adjustment to adults with type 1 or type 2 diabetes mellitus

More information

Introducing DEXCOM STUDIO INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT

Introducing DEXCOM STUDIO INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT Introducing DEXCOM STUDIO Continuous Glucose Monitoring Software INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT Glucose Pattern Management A Guide to Interpreting

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

Updates for your practice March, 2013. Vol 2, Issue 14 TLALELETSO. Managing Complicated Diabetes

Updates for your practice March, 2013. Vol 2, Issue 14 TLALELETSO. Managing Complicated Diabetes dates for your practice March, 2013. Vol 2, Issue 14 TLALELETSO Managing Complicated Diabetes Diabetes is increasingly common Managing diabetes and working as part of a multidisciplinary team is essential

More information

Statistics of Type 2 Diabetes

Statistics of Type 2 Diabetes Statistics of Type 2 Diabetes Of the 17 million Americans with diabetes, 90 percent to 95 percent have type 2 diabetes. Of these, half are unaware they have the disease. People with type 2 diabetes often

More information

INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco

INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic

More information

Managing the risks of commencing insulin therapy for patients with type 2 diabetes

Managing the risks of commencing insulin therapy for patients with type 2 diabetes Managing the risks of commencing insulin therapy for patients with type 2 diabetes Laila King June 213 213 The Health Foundation Insulin is a remedy primarily for the wise, and not for the foolish, whether

More information

Cochrane Quality and Productivity topics

Cochrane Quality and Productivity topics Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus NICE has developed the Cochrane Quality and Productivity (QP) topics to help the NHS identify practices

More information

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation

More information

[Frida Svendsen and Jennifer Southern] University of Oxford. October 2014

[Frida Svendsen and Jennifer Southern] University of Oxford. October 2014 In adolescents with poorly controlled type 1 diabetes mellitus, could a bionic, bihormonal pancreas provide better blood glucose control than continuous subcutaneous insulin infusion therapy? [Frida Svendsen

More information

INTERNATIONAL DIABETES CENTER A LEADER IN DIABETES INNOVATION, EDUCATION AND RESEARCH

INTERNATIONAL DIABETES CENTER A LEADER IN DIABETES INNOVATION, EDUCATION AND RESEARCH INTERNATIONAL DIABETES CENTER A LEADER IN DIABETES INNOVATION, EDUCATION AND RESEARCH FACING THE DIABETES EPIDEMIC Diabetes affects more than 280 million people worldwide. That number is expected to reach

More information

Student pharmacists level of confidence in providing DSME prior to entering P4 rotations

Student pharmacists level of confidence in providing DSME prior to entering P4 rotations Student pharmacists level of confidence in providing DSME prior to entering P4 rotations Meredith Tate, PharmD Candidate 2016; Kristi Kelley, PharmD, FCCP, BCPS, CDE, BC-ADM Auburn University Harrison

More information

Diabetes Medications: Insulin Therapy

Diabetes Medications: Insulin Therapy Diabetes Medications: Insulin Therapy Courtesy Univ Texas San Antonio Eric L. Johnson, M.D. Department of Family and Community Medicine Diabetes and Insulin Type 1 Diabetes Autoimmune destruction of beta

More information

Causes, incidence, and risk factors

Causes, incidence, and risk factors Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,

More information

Management of Diabetes

Management of Diabetes Management of Diabetes Blood Glucose Monitoring MANAGEMENT OF DIABETES Once someone is told they have diabetes, they are usually asked to check their blood glucose at home with a home blood glucose meter

More information